Salvianolic Acid B Protects Against Contrast‐Induced Acute Kidney Injury by Attenuating Ferroptosis via the SIRT1 /Nrf2 Pathway
The FASEB Journal · 30.06.2026 · 40 (12)
DOI: 10.1096/fj.202600450rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 16.06.2026. Verfasst von Hongtao Yuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: First Central Hospital of Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Ferroptosis, Benzofurans, NF-E2-Related Factor 2, Acute Kidney Injury. Die Arbeit nennt 34 Literaturangaben. Gefördert von: MOST|National Natural Science Foundation of China (NSFC), Health Science and Technology fund of Tianjin, Tianjin Key Medical Discipline Construction Project.
Abstract (Originalsprache)
Contrast‐induced acute kidney injury (CI‐AKI) poses a significant clinical challenge and contributes to a considerable healthcare burden. Ferroptosis has been increasingly recognized as an important mechanism of renal tubular epithelial cell injury in CI‐AKI. Salvianolic acid B (SalB), a natural compound with anti‐inflammatory and antioxidant properties, has shown protective effects in various kidney diseases. However, its role in CI‐AKI‐associated ferroptosis has not been fully clarified. In this study, we established a rat model of CI‐AKI by subcutaneous injection of carbon tetrachloride for 6 weeks followed by iopamidol administration, and an in vitro model using iopamidol‐treated HK‐2 cells. Effects of tubular injury and ferroptosis were examined both in vivo and in vitro. Cycloheximide chase assay, cellular thermal shift assay, and molecular docking were used to assess the binding capacity of SalB to SIRT1. Our results showed that SalB significantly alleviated renal injury, reduced iron accumulation, oxidative stress levels, and lipid peroxidation, upregulated the expression of SLC7A11 and GPX4, and downregulated ACSL4 expression in both iopamidol‐treated rat kidneys and HK‐2 cells. Mechanistically, SalB targeted and bound to SIRT1, enhancing its stability, thereby promoting Nrf2 upregulation and nuclear translocation, which in turn enhanced the expression of SLC7A11 and GPX4 and attenuated ferroptosis. Silencing either SIRT1 or Nrf2 in HK‐2 cells partially abrogated the protective effect of SalB. Collectively, our results support SalB as a viable treatment strategy for CI‐AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Central Hospital of Tianjin Medical University, Tianjin, China.
- The School of Medicine, Nankai University, Tianjin, China.
- MR Research Collaboration, Siemens Healthineers, Beijing, China.
- Department of Radiology, Tianjin First Central Hospital, Tianjin Institute of Imaging Medicine, Tianjin, China.
ORCID-Profile: Wen Shen
Förderung
- MOST|National Natural Science Foundation of China (NSFC)
- Health Science and Technology fund of Tianjin
- Tianjin Key Medical Discipline Construction Project
- National Natural Science Foundation of China
Zitieren
APA
Yuan, H., Shi, X., Qin, J., Wang, Y., Yuan, Y., Zhang, Y., Wang, Y., Zhang, C., Zhu, J., Chen, L., Xie, S., & Shen, W. (2026). Salvianolic Acid B Protects Against Contrast‐Induced Acute Kidney Injury by Attenuating Ferroptosis via the SIRT1 /Nrf2 Pathway. The FASEB Journal, 40(12). https://doi.org/10.1096/fj.202600450rr
Vancouver
Yuan H, Shi X, Qin J, Wang Y, Yuan Y, Zhang Y, et al. Salvianolic Acid B Protects Against Contrast‐Induced Acute Kidney Injury by Attenuating Ferroptosis via the SIRT1 /Nrf2 Pathway. The FASEB Journal. 2026;40(12). doi:10.1096/fj.202600450rr
BibTeX
@article{Yuan2026,
author = {Yuan, Hongtao and Shi, Xiang and Qin, Jiaming and Wang, Yue and Yuan, Yinuo and Zhang, Yutong and Wang, Yiran and Zhang, Chen and Zhu, Jinxia and Chen, Lihua and Xie, Shuangshuang and Shen, Wen},
title = {Salvianolic Acid B Protects Against Contrast‐Induced Acute Kidney Injury by Attenuating Ferroptosis via the SIRT1 /Nrf2 Pathway},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {12},
doi = {10.1096/fj.202600450rr}
}
EUVIMED